Diabetes Care in The Netherlands: - Novo Nordisk

More documents

Recommendations

Info

High quality care leads to excellent outcome values and to fewercomplicationsCASE EXAMPLESDiabetesZorgBeter 1 st line protocolreduces risk of major complicationsFrequency of diabetic complications(2008)PoZoB achieves HbA1c objectives with~70% of the patients – also improvementsin blood pressure and cholesterol levelsIndicators DM (2007 -2010)Through personalized coaching Kaiserpermanente reduces HbA1c by 1.2%Change HbA1c values (1999)ChronicheartfailureAcute 0.7%heartfailure 0.3%2.1%1.0%HbA1c < 7% (
Better compliance can be stimulated and leads to fewerhospitalizationsBetter compliance can be stimulated and leads to fewerCASE EXAMPLESMedical cost of fully compliant patients up to half ofnon-compliant patientsAverage Expenditure per year (USD, 2005)44% reduction in hospitalizations atKaiser permanente programHospitalization/1000 persons -months (1999)$8,878-49%$7,124$6,522$6,29127-44%$4,571151-19%20-39%40-59%60-79%Compliance Levels (% Days Supply / 1 Year)80-100%ControlgroupKaiserpermanenteMain interventions• Compliance to treatment plan:- Medication- Doctor’s visits- Lifestyle advice (quit smoking, etc.)Main interventions• Focus on poorly managed diabetespatients• Personalized coaching• Patient networks on- and off-lineSource: Sokol M et al. Impact of Medication Adherence on Hospitalization Risk and Healthcare cost, Kaiser permanente, Booz & Company analysisBooz & Company 14 November 2011Prepared for Novo Nordisk2229
Page 6 and 7: SummaryDiabetes is a serious and de
Page 8: diabetes care. Extra compensation w
Page 11 and 12: ContentsSummarized findings and rec
Page 13 and 14: 11Diabetes is a major and underesti
Page 15 and 16: 33Further improving health of of di
Page 17 and 18: 22Recommendation 2: Engage employer
Page 19 and 20: 44Recommendation 4: Introduce condi
Page 21 and 22: Already more than 1M diabetes patie
Page 23 and 24: Costs of of complications and treat
Page 25 and 26: Number of patients reaches ~1.4M in
Page 27 and 28: Increase in lost productivity is dr
Page 29: Diabetes care clearly improved in t
Page 37 and 38: Delaying complications saves medica
Page 39 and 40: LimitedLimitedcollaborationcollabor
Page 41 and 42: Individual quality incentives are l
Page 43 and 44: Recommendation 1: Insurer should in
Page 47 and 48: Labour shortage from late nineties
Page 49 and 50: However, curative and participative
Page 53 and 54: Non-compliance leads to severe comp
Page 55: Facilitated patient networks are su
Page 58 and 59: Recommendation 3:Facilitate network
Page 62 and 63: But new medication could add a lot
Page 66: Booz & Company is a global manageme

Diabetes Care in The Netherlands: - Novo Nordisk

Create successful ePaper yourself

Delete template?

Save as template?